|
A Study Comparing 4 Doses Of S-1360 Versus Placebo In HIV-Infected Patients. Clinical Trials Data presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, calls or treatment using a genuine doctor. We are not docs. Always consult your dr. on A Study Comparing 4 Doses Of S-1360 Versus Placebo In HIV-Infected Patients. conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. A Study Comparing 4 Doses Of S-1360 Versus Placebo In HIV-Infected Patients. Clinical research trials and A Study Comparing 4 Doses Of S-1360 Versus Placebo In HIV-Infected Patients. healthcare trials occur in a lot of of places throughout the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the potency of new drugs. The intent of the studies / undertakings is to figure out certain human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations to locate remedies for all kinds of circumstances, including A Study Comparing 4 Doses Of S-1360 Versus Placebo In HIV-Infected Patients.. A Study Comparing 4 Doses Of S-1360 Versus Placebo In HIV-Infected Patients. Clinical Trials and other clinical trials allow volunteers to obtain health treatment alternatives before they are available to the masses. Many times the participants undergo treatment for free, and sometimes they are paid for their time. Occasionally there is a cost for a A Study Comparing 4 Doses Of S-1360 Versus Placebo In HIV-Infected Patients. clinical trial. Participants typically obtain the most effective healthcare available for their A Study Comparing 4 Doses Of S-1360 Versus Placebo In HIV-Infected Patients. condition. Dangers are a reality, nonetheless, and can include extra or frequent mD trips, medical hazards (potentially life-endangering), and/or the treatment being uneffective. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Study Comparing 4 Doses Of S-1360 Versus Placebo In HIV-Infected Patients.  A Study Comparing 4 Doses Of S-1360 Versus Placebo In HIV-Infected Patients.
A Study Comparing 4 Doses Of S-1360 Versus Placebo In HIV-Infected Patients.
For Condition: HIV Infections
Status: Completed
Sponsor(s): Sponsor Name Pending ,
Synopsis: This study will evaluate the drop in viral load over 10 days of treatment with S-1360 versus placebo in HIV-infected patients who have not previously taken anti-HIV medications.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: (Subjects must meet the following criteria in order to be eligible for this study.): - No prior HIV medications. - HIV infection with viral load >400-50,000 copies/mL - CD4 cell count >50 cells/mm - Male or female - At least 18 years of age
Total Enrollment:
Location and Contact Information:
Study Site
Chapel Hill, North Carolina, 27599
United States
Study Site
Phoenix, Arizona, 85006
United States
Study Site
New York City, New York, 10008
United States
Study Site
Minneapolis, Minnesota, 55404
United States
Study Site
New York City, New York, 10011
United States
Study Site
Miami, Florida, 33133
United States
Study Site
Washington D.C., District of Columbia, 20007
United States
Study Site
West Hollywood, California, 90069
United States
Study Site
Tampa, Florida, 33614
United States
Study Site
New York City, New York, 10032
United States
Study Site
Indianapolis, Indiana, 46202
United States
Study Site
Ft. Lauderdale, Florida, 33311
United States
Study Site
San Francisco, California, 94115
United States
Study Site
Denver, Colorado, 80220
United States
Study Site
San Diego, California, 92103
United States
Study Site
Houston, Texas, 77004
United States
Study Site
Charlotte, North Carolina, 28203
United States
Study Site
Bronx, New York, 10461
United States
Study Site
Durham, North Carolina, 27710
United States
Study Site
Los Angeles, California, 90048
United States
Study Site
Atlanta, Georgia, 30308
United States
Study Site
Altamonte Springs, Florida, 32701
United States
Study Site
Dallas, Texas, 75235
United States
Additional Information:
Study ID Numbers: ITG20001;
Study Start Date:
Record last reviewed: January 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00046332
Other Hiv Infections Studies:
1. Comparing Side Effects of Two Forms of Videx in HIV-Infected Adults
2. A Study to Compare the Effectiveness of Different Anti-HIV Drug Regimens in Keeping Levels of HIV in the Blood as Low as Possible
3. Long-Term Effects of HAART in Youth with Stronger Immune Systems Versus Youth with Weaker Immune Systems
4. The Effectiveness of Human Antibodies in Influencing an AIDS-Like Disease in Monkeys
5. A Study of CI-1012 in HIV-Infected Patients
Related Studies:
Other HIV Infections Clinical Trials
Other Georgia Clinical Trials
Other Atlanta Clinical Trials
A Study Comparing 4 Doses Of S-1360 Versus Placebo In HIV-Infected Patients.
|
|
|
|
|
|
|
|
